Navigation Links
Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
Date:7/23/2012

CAMBRIDGE, Mass., July 23, 2012 /PRNewswire/ -- Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.

Having completed enrollment of a 150-patient randomized Phase 2 study in advanced non-small cell lung cancer, Cerulean is beginning to capitalize on the breadth of the CRLX101 opportunity by expanding its development into additional tumor types with several studies conducted by leading investigators.  This newly opened trial is designed to evaluate the activity of CRLX101, a nanopharmaceutical that inhibits both topoisomerase 1 and hypoxia-inducible factor-1 alpha, in ovarian cancer patients whose disease has progressed following standard first-line platinum-based therapy.  Current approved second-line therapy for ovarian cancer includes use of the topoisomerase 1 inhibitor, topotecan, which has limitations.  The study is being conducted at the Massachusetts General Hospital and led by principal investigator Carolyn Krasner, M.D., in cooperation with the Dana Farber Cancer Institute, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center.  

"Not only do women with advanced stage ovarian cancer have limited treatment options, but they also suffer from many disease-related symptoms and treatment-related side effects," said Dr. Krasner.  "This study will enable us to evaluate the potential use of CRLX101 as a treatment option for those patients." 

"This trial is intended to build on our current clinical data and determine if CRLX101 can offer ovarian cancer patients a new treatment option," said Edward Garmey, M.D., chief medical officer of Cerulean.  "We are excited to partner with Dr. Krasner and to expand the development strategy of CRLX101 in an indication w
'/>"/>

SOURCE Cerulean Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria
2. Kraton Performance Polymers, Inc. Announces Second Quarter 2012 Earnings Release Conference Call and Webcast and 2012 Investor Day and Webcast
3. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
4. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
5. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. China Health Resource Announces Go Global Initiative For New Product Introductions
7. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. PDI, Inc. Announces Client FDA Product Approval Related to Previously Disclosed Contract
9. Ampio Pharmaceuticals Announces Closing of Public Offering
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  Casen Buswell has a rare vascular condition ... His case is one of only 14 known cases of ... hospital in the United States , and ... with the dual wave-length laser, is Methodist Children,s Hospital, a ... . Using a laser available in South Texas ...
(Date:9/18/2014)... Sept. 18, 2014   Fruit Street Health ... initial seed round of funding. The ... by a series of individual investors, the majority of ... in the initial round are; Houston Cardiology Consultants ... Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... -- Pharma IQ, after huge ... Serialisation Countdown calendar to cover the years 2014 - ... shows the serialisation requirements around the globe and ... force. For companies dealing with international markets, ... "when" they will have to comply with new regulations ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
... 2011 / PRNewswire/ -- Fleming Pharmaceuticals, ... iodide product indicated for thyroid protection in radiation emergencies ... necessary to ramp up production to meet increased domestic ... an over-the-counter iodide solution which, when taken orally, saturates ...
Cached Medicine Technology:Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
(Date:9/18/2014)... Stealth Health Revolution co-founders, Montel ... Frank Davis, founder of Food for Health International ... to announce the new recipe book, "The Simple ... meals using Activz whole-food powders." The Simple ... the Stealth Health Revolution mission to ...
(Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded the ... grant to the Los Angeles Biomedical Research Institute (LA ... a vaccine to protect patients from the healthcare-related infections, ... (MRSA). , The National Institute of Allergy and ... to LA BioMed infectious disease specialists John E. Edwards, ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 With the ... availability of products such as smart phones, tablets and ... in the way mobile devices are viewed these days. ... personal data to becoming a mode for creating and ... come a long way. , The complete ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Once again, ... favorite breakfast restaurants around the Valley to celebrate PJs ... on “World Egg Day”: Friday, October 10, 2014. The ... participating locations to benefit Arizona’s Children Association (AzCA) foster ... for dinner at each participating restaurant on October 10 ...
Breaking Medicine News(10 mins):Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 2Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Transparency Market Research: M-health Market Study 2018 2Health News:Transparency Market Research: M-health Market Study 2018 3Health News:Transparency Market Research: M-health Market Study 2018 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... fat in hot dogs, sausages, hamburgers and other foods with ... mystery of why hot dogs develop an unpleasant tough texture ... on their study appears in ACS, Journal of Agricultural ... explain that some brands of sausage (frankfurters) have been reformulated ...
... -- In a novel therapeutic approach to treating breast cancer, ... a clinical trial of a drug that targets tumor stem ... cells. But a handful of cancer stem cells are resistant ... into new tumor cells., A pilot study at Loyola found ...
... Serious traumatic injuries, including major burns, set off a ... percent of the cells, normal gene expression patterns. ... Journal of Experimental Medicine , members of a nationwide ... into the immune system response to serious injury, findings ...
... University Press (OUP) is pleased to announce the acquisition of two ... Journal of Chromatographic Science ( JCS ), from Preston ... these two titles sees the continued strengthening of the STM journal ... be able to take on the publishing for these two titles. ...
... 7 (HealthDay News) -- Some endurance athletes may suffer damage ... do not suggest that this type of exercise is unhealthy, ... four chambers in the heart involved in pumping blood. ... in one of four types of endurance events: marathons, endurance ...
... (irregular) schedule that includes three or more night shifts per ... that month, may have an increased risk of developing type ... or evenings, according to a new study led by researchers ... researchers found that extended years of rotating night shift work ...
Cached Medicine News:Health News:Novel approach to treating breast cancer shows great promise 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 3Health News:Oxford University Press acquires 2 journals from Preston Publications 2Health News:Marathons May Damage Part of Heart: Study 2Health News:Rotating night shift work linked to increased risk of Type 2 diabetes in women 2
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
... a solid made, manual plate washer ... for dispense and aspirate function ensure ... with a stand and all necessary ... used, as well as any bottles ...
MW 96-W1 microplate washer with one wash line....
Full automatic, ready-to-use strip washer....
Medicine Products: